EXMceuticals Inc. names Paulo Martins as Chief Executive Officer for Portugal operations
14 janv. 2020 09h00 HE
|
EXMceuticals Inc.
VANCOUVER, British Columbia, Jan. 14, 2020 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), a producer of cannabis extractions and refined ingredients for the...
CB2 Insights 2019 Year In Review – A Message from CEO and Co-Founder Pradyum Sekar
08 janv. 2020 07h30 HE
|
CB2 Insights
TORONTO, Jan. 08, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the...
CB2 Insights Announces Collaboration with FCM Global to Support Medical Cannabis R&D in Colombia
03 déc. 2019 07h30 HE
|
CB2 Insights
TORONTO, Dec. 03, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence-driven from the...
Aleafia Health Completes $7.1M Cannabis Sale Agreement
02 déc. 2019 07h00 HE
|
Aleafia Health Inc.
TORONTO, Dec. 02, 2019 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has reached a definitive Cannabis Material Purchase Agreement...
Aleafia Health Launches International Medical Cannabis White Label Services
28 nov. 2019 07h00 HE
|
Aleafia Health Inc.
TORONTO, Nov. 28, 2019 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has completed production of its first white label production run...
CB2 Insights to Participate at Piper Jaffray’s 31st Annual Healthcare Conference
14 nov. 2019 07h30 HE
|
CB2 Insights
TORONTO, Nov. 14, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence-driven from the...
CB2 Insights Announces Record Preliminary Unaudited Q3 2019 Revenue of $4.2 Million and Details for Earnings Call
01 nov. 2019 08h00 HE
|
CB2 Insights
CB2 Insights’ Q3 2019 preliminary unaudited revenue saw a sequential growth of approximately 29% compared to the previous quarterCompany’s Q3 preliminary Adjusted-EBITDA loss was significantly reduced...
VIVO and CB2 Insights Enter Technology and Research Partnership
29 oct. 2019 07h48 HE
|
CB2 Insights
Partnership to focus on implementing a medical product development strategy for VIVO’s global medical cannabis offering, utilizing CB2 Insights’ leading technology platform Sail and research...
EXMceuticals obtains its research and development license for its TecLab facilities in Portugal
23 oct. 2019 09h00 HE
|
EXMceuticals Inc.
VANCOUVER, British Columbia, Oct. 23, 2019 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), a cultivator and producer of high-grade cannabis is pleased to...
Aleafia Health Provides Guidance for Profitable Third Quarter 2019
24 sept. 2019 07h00 HE
|
Aleafia Health Inc.
Company maintains strong balance sheet with $51 million in cash on handConstruction of Paris Phase II Processing facility expected to be completed in October 2019Active, registered patients increased...